Changes in Lung Clearance Index in Preschool-aged Patients with Cystic Fibrosis Treated with Ivacaftor (GOAL): A Clinical Trial

Am J Respir Crit Care Med. 2018 Aug 15;198(4):526-528. doi: 10.1164/rccm.201802-0243LE.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminophenols / therapeutic use*
  • Child, Preschool
  • Chloride Channel Agonists / therapeutic use*
  • Cystic Fibrosis / drug therapy*
  • Female
  • Humans
  • Lung / drug effects*
  • Lung / physiopathology*
  • Male
  • Quinolones / therapeutic use*
  • Treatment Outcome

Substances

  • Aminophenols
  • Chloride Channel Agonists
  • Quinolones
  • ivacaftor